Skip to content

13F-HR filed by Finepoint Capital LP

Finepoint Capital LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-10, with 57 holding rows worth $304,049,000.

Accession
0001567619-22-019422
Filed
2022-11-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 57 entries on the cover page, a total value of $304,049,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $304,048,000 with VALUE read as thousands by filing date, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TRAVERE THERAPEUTICS INC89422G107COM1,028,875$25,351,000thousands by filing date
ALGOMA STL GROUP INC015658107COM3,716,732$23,936,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock305,400$18,516,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW380,793$18,449,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,111,030$18,176,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM266,090$18,174,000thousands by filing date
ARVINAS INC04335A105COM399,000$17,752,000thousands by filing date
IVERIC BIO INC46583P102COM987,600$17,718,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,688,400$17,627,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM646,586$16,915,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM429,313$16,812,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR379,702$16,190,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM1,586,043$15,194,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U128COM536,901$15,173,000thousands by filing date
DISH NETWORK CORPORATION25470MAF6NOTE 12/120,000,000$13,220,000thousands by filing dateprincipal
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR123,400$12,742,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR28,770$10,157,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM308,092$8,790,000thousands by filing date
Global Business Travel Group I37890B118Warrant913,000$1,433,000thousands by filing date
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/202895,000$116,000thousands by filing date
ZIMMER ENERGY TRANSITION ACQ989570114*W EXP 06/16/202358,270$111,000thousands by filing date
CONYERS PARK III ACQSITN COR21289P110*W EXP 08/12/202571,666$104,000thousands by filing date
STARRY GROUP HOLDINGS INC85572U110WTS669,000$87,000thousands by filing date
CONCORD ACQUISITION II CORP20607u116WT408,333$86,000thousands by filing date
CHURCHILL CAPITAL CORP VI17143W119*W EXP 02/17/202540,000$76,000thousands by filing date
CHURCHILL CAPITAL CORP VII17144M110*W EXP 02/29/202548,000$74,000thousands by filing date
SUMMIT HEALTHCRE ACQUISTN COG8566R110*W EXP 06/03/202489,999$74,000thousands by filing date
Gores Technology Partners II Inc38287L115Warrant450,691$72,000thousands by filing date
KKR ACQUISITION HOLDING I CO48253T117WTS588,547$71,000thousands by filing date
JAWS HURRICANE ACQUISITN COR47201B111*W EXP 03/26/202387,249$65,000thousands by filing date
AFTERNEXT HEALTHTECH ACQUISIG01109126*W EXP 99/99/999366,666$59,000thousands by filing date
ARES ACQUISITION CORPORATIONG33032122*W EXP 02/02/202504,706$58,000thousands by filing date
FORTRESS VALUE ACQUISI CORP34964K116*W EXP 03/18/202306,513$54,000thousands by filing date
CHURCHILL CAPITAL CORP V17144T115*W EXP 10/29/202612,000$52,000thousands by filing date
BERENSON ACQUISITION CORP I083690115*W EXP 08/01/202862,499$44,000thousands by filing date
SKYDECK ACQUISITION CORPG82220115*W EXP 05/13/202361,756$42,000thousands by filing date
COMPASS DIGITAL ACQUISITION COg2476c123WT459,906$41,000thousands by filing date
GORES TECHNOLOGY PARTNERS IN382870111*W EXP 03/16/202201,000$38,000thousands by filing date
CATALYST PARTNRS ACQUISITN CG19550121*W EXP 05/12/202336,666$37,000thousands by filing date
CALIDI BIOTHERAPEUTICS INC320703119*W EXP 03/14/202655,200$37,000thousands by filing date
BILANDER ACQUISITION CORP09001T114*W EXP 05/19/202183,749$36,000thousands by filing date
ROSS ACQUISITION II CORPg7641c114WT439,666$34,000thousands by filing date
FORTRESS CAPITAL ACQUISITIONG36427121WARR392,000$31,000thousands by filing date
CORSAIR PARTNERING CORPG2540H116*W EXP 07/06/202334,666$28,000thousands by filing date
SWIFTMERGE ACQUISITION CORPG63836111*W EXP 12/13/202490,000$25,000thousands by filing date
FORTRESS VALUE ACQUIS CORP I34964G115*W EXP 12/31/202225,000$23,000thousands by filing date
SIMON PROPERTY GRP ACQ HOLDI82880R111*W EXP 02/04/202335,200$22,000thousands by filing date
COHN ROBBINS HOLDINGS CORPG23726113*W EXP 08/28/202904,000$21,000thousands by filing date
HEALTH ASSURN ACQUISITION CO42226W117*W EXP 11/12/202643,000$19,000thousands by filing date
HOME PLATE ACQUISITION CORP43734R111*W EXP 09/30/202690,000$17,000thousands by filing date
REVOLUTION HEALTHCAR AQ CORP76155Y116*W EXP 12/31/202432,639$17,000thousands by filing date
MARBLEGATE ACQUISITION CORP56608A113*W EXP 08/31/202735,000$16,000thousands by filing date
LEVERE HOLDINGS CORPG5462L122*W EXP 03/09/202274,999$14,000thousands by filing date
SENIOR CONNECT ACQUISITN COR81723H116*W EXP 12/31/2021,014,000$10,000thousands by filing date
WARBURG PINCUS CAPTAL CORP IG9460M124WARR125,000$8,000thousands by filing date
THE MUSIC ACQUISITION CORP62752R118*W EXP 02/05/20275,250$3,000thousands by filing date
Warburg Pincus Capital Corp I-AG9461D115Warrant14,999$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-019422this filing2022-11-10acceptance time not in the bulk data set